Press releases
Hogan Lovells advises MorphoSys on its delisting from the stock exchange and the public delisting tender offer by Novartis
20 August 2024
Under the joint lead of Frankfurt partner Prof Dr Michael Schlitt and Munich counsel Dr Sebastian Biller, global law firm Hogan Lovells has advised MorphoSys AG ("MorphoSys") in connection...